Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
1
x
$
30.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
1
x
$
30.00
Farmacoterapias: Lineamientos del concenso de expertos para el tratamiento farmacológico del trastorno bipolar: una nueva herramienta terapéutica
1
x
$
0.00
Caso clínico: Koro en trastorno esquizofreniforme
1
x
$
0.00
Remission as the Critical Outcome of Depression Treatment
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Psiquiatría social: Las mujeres centroamericanas y la psiquiatría
1
x
$
0.00
Ahmad Ghanizadeh - Does Risperidone Improve Hyperacusia in Children with Autism?
1
x
$
30.00
VOL 2 No. 4 Full Issue - April 2000
1
x
$
20.00
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
1
x
$
30.00
View Cart
Checkout
Home
neuroleptics
“Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
$
30.00
Add to cart
Details
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
$
30.00
Add to cart
Details
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
$
30.00
Add to cart
Details
Page load link
Go to Top
